SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 15, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago
Insider cluster: 5 insiders, $0.4M total
Actionable Insight • Neutral

The selling is modest and likely liquidity-driven. Monitor for any upcoming corporate events (e.g., pipeline milestones or earnings) that could explain the timing, but this cluster does not warrant a defensive trade on its own.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$5.65
T+0 close · Jun 15, 2026 · via day close
Latest settled
+24.96%
T+20 · $7.06
Vs SPY
+24.76%
α at T+20
Next horizon
T+60
due 2mo ago
  1. T+0 · Jun 16 $5.65entry
  2. T+1 · 5mo ago 0.00%α +1.25% · $5.65
  3. T+5 · 5mo ago +1.24%α +3.47% · $5.72
  4. T+20 · 4mo ago +24.96%α +24.76% · $7.06
  5. T+60 · due 2mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five ABEO insiders, including the CEO and CFO, sold a total of $407K in shares over a 7-day window. The selling represents 0.13% of market cap, a modest amount that is typical of routine diversification or liquidity needs rather than a strong negative signal.

Key Financial Metrics

Direction
selling
Total Value
$407.0K
Insiders
5

Key Facts

  • CEO Vishwas Seshadri sold 31.9K shares ($169K) on June 9.
  • CFO Joseph Vazzano sold 13.4K shares ($71K) on June 9.
  • Director Christine Silverstein sold 18.2K shares ($104K) on June 15.
  • Total insider sales of $407K represent 0.13% of ABEO's $322M market cap.
  • All sales were open-market transactions; no 10b5-1 plan disclosures are noted.

Financial Impact

Insider sales of $407K total, modest relative to $322M market cap (0.13%).

Risk Factors

  • Insider selling could accelerate if negative news emerges.
  • Biotech sector volatility may amplify any sentiment shift.
  • Further selling from C-suite could signal waning confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABEO-1781728397497

Track record

29 reports on ABEO

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry price pending
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  5. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
  6. Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  7. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
  8. Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
  9. Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
  10. Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (9h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026